Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
Crossref DOI link: https://doi.org/10.1007/s40121-023-00823-z
Published Online: 2023-06-17
Published Print: 2023-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reau, Nancy
Cheng, Wei-Han
Shao, Qiujun
Marx, Steven E.
Brooks, Hannah
Martinez, Anthony
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2023-06-17
Version of Record valid from 2023-06-17
Article History
Received: 20 September 2021
Accepted: 16 May 2023
First Online: 17 June 2023